Last year brought successes and challenges for the Interlink Healthcare Group, which is comprised of four units: IneXel, a global med ed/CME group; I-link, a multimedia/interactive group; Ingrafik, an art and design group, and Interlink Healthcare Communications (IHC), a full-service advertising and promotion agency. IHC got a lift from Covance Periapproval Services with an account of record win, and picked up another AOR on BEMA Fentanyl, Meda Pharmaceuticals' pain medication in development. Imclone, a Bristol-Myers Squibb company, tapped IHC for Erbitux, a colorectal, head and neck oncology product. In 2008, Interlink will continue to foster its I-link unit, providing flash emails, e-media and other interactive solutions.
Pages to are hidden for
"Interlink Healthcare Communications"Please download to view full document